Wiley Blackwell

SHERPA: Unknown

People

  1. Yahalom
    Yahalom
  2. Imber
    Imber
  3. Fregonese
    Fregonese
  4. Palomba
    Palomba
  5. Salles
    Salles
  6. Zelenetz
    Zelenetz
  7. Kumar
    Kumar
  8. Moskowitz
    Moskowitz
  9. Noy
    Noy
  10. Dogan
    Dogan

Groups

  1. Radiation Oncology, Department of (43)
  2. Survivorship Research (43)
  3. Department of Medicine (27)
  4. Hematologic Malignancies, Division of (27)
  5. Center for Hematologic Malignancies (23)
  6. Lymphoma (18)
  7. GME, Radiation Oncology (16)
  8. Graduate Medical Education (16)
  9. Sloan Kettering Institute Postdocs (16)
  10. Epidemiology and Biostatistics (11)
Search Within
  1. "Joachim Yahalom"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (10)
Groups
  1. Radiation Oncology, Department of (43)
  2. Survivorship Research (43)
  3. Department of Medicine (27)
  4. Hematologic Malignancies, Division of (27)
  5. Center for Hematologic Malignancies (23)
  6. Lymphoma (18)

More Groups

People
  1. Joachim Yahalom (43)
  2. Brandon Imber (21)
  3. Carla Hajj (15)
  4. Beatrice Fregonese (11)
  5. David Straus (10)
  6. Maria Palomba (10)

More People

Years
  1. 2023 (20)
  2. 2021 (2)
  3. 2019 (8)
  4. 2017 (5)
  5. 2015 (2)
  6. 2008 (1)

More Years

Publications
  1. Hematological Oncology (34)
  2. Cancer (7)
  3. Cancer Medicine (1)
  4. Journal of Surgical Oncology (1)

Results (43)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolving consolidation patterns and modern outcomes for a large longitudinal cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B. S.; Tringale, K.; White, C.; Zhang, Z.; Scordo, M.; Yahalom, J.; Grommes, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Treatment outcomes of limited stage grade 3A follicular lymphoma
    Meeting Abstract

    Sarkar, R. R.; Lee, J.; Zhang, Z.; Zelenetz, A.; Salles, G.; Yahalom, J.; Imber, B.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A single‐center experience of low‐dose radiotherapy for primary extranodal marginal zone lymphoma of bronchus‐associated lymphoid tissue (BALT)
    Meeting Abstract

    Freret, M. E.; Tringale, K. R.; Imber, B. S.; Joffe, E.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Genomic correlates of radiosensitivity in diffuse large B cell lymphoma
    Meeting Abstract

    Sarkar, R. R.; Ma, J.; Wijetunga, N. A.; Salles, G.; Joffe, E.; Imber, B.; Yahalom, J.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Genetic alterations in follicular lymphoma predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Lee, J.; Fregonese, B.; Hajj, C.; Cedarquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Very low dose radiation therapy for indolent lymphoma: Comparing "Big Boom" (4GY × 1) versus "Boom Boom" (2GY × 2)
    Meeting Abstract

    Hajj, C.; Lee, J.; Boe, L.; Fregonese, B.; Lebow, E.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K.; Freret, M.; Imber, B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save